Necdet Uskent
- 4.6 Excellent • 494 reviews
- 45 years of experience
- Turkey, Istanbul, Anadolu Medical Center
Professor of Oncology and Hematology
Professor of Oncology and Hematology
Dr. Rashad Rzazade is a skilled radiation oncologist. He specializes in advanced cancer treatments, including IMRT, SRT, proton therapy, and CyberKnife. He has strong experience treating head and neck cancers, brain tumors, lung, spine, cervical, and gastrointestinal cancers.
Dr. Rzazade trained at Azerbaijan Medical School, Hacettepe University, and Marmara University. He also gained international experience at MD Anderson Cancer Center. He has treated thousands of patients and is known for high survival rates and patient satisfaction in complex cancer cases.
Prof. Dr. Cem Iyibozkurt is a respected Gynecologic Oncologist and Professor of Obstetrics & Gynecology. He is known for his skill in minimally invasive and robotic surgery. Dr. Iyibozkurt holds a PhD in Molecular Medicine. He has completed advanced training in Oxford, Leeds, and Florida. He combines innovative research with strong clinical practice.
Dr. Iyibozkurt is a leader in robotic-assisted gynecologic oncology surgeries. He has performed hundreds of minimally invasive procedures. These surgeries help reduce patient recovery times and lower surgical risks. He is accredited by the European Society of Gynaecological Oncology and the Turkish Society of Gynecologic Oncology. These accreditations show his dedication to high standards of care.
Dr. Iyibozkurt currently practices at Istanbul Florence Nightingale Hospital. He provides evidence-based treatments and is recognized for advanced gynecologic oncology care.
Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.
She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).
In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.
Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.
Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.
In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.
Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.
She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.
She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).
Dr. Balaña received her medical degree from the Central University of Barcelona and completed her residency in medical oncology at one of the best public hospitals in Spain, Vall d'Hebrón Hospital.
She was a leading specialist in the treatment of brain tumors at the Institute of Oncology of Catalonia, a founding member and current president of the Spanish Neuro oncology Research Group (GEINO), and a member of the scientific committee of the European Association for Neuro-Oncology.
He is the recipient of prestigious research grants in the field of brain tumors.
Dr. Balaña is also a member of the European Society of Medical Oncology and the author of modern European protocols for the treatment of brain tumors, as well as the protocols of the Spanish Society of Medical Oncology (SEOM).
Dr. Balaña has published over 400 articles, books and scientific papers at national and international conferences.
He is the author of articles in prestigious scientific publications such as:
Lancet Oncology;
Nature Reviews in Clinical Oncology;
Clinical Cancer Research and others.
20 top ranked Oncology doctors in the world are represented on this page. The list includes only verified specialists known for their experience and high success rates.
The ranking is composed according to the Bookimed patient reviews and considers the rating of hospitals where doctors practice.
Top 5 Oncology doctors on Bookimed.com:
The specialist’s CV contains details about the doctor’s expertise and work experience, education, scientific research, and languages spoken. Compare information on several specialists, read carefully about their experience, success rates, and methods they apply. Make sure the chosen doctor has relevant experience in the treatment of a medical issue you are looking for. Read reviews of patients who had a consultation with the chosen specialist.
Famous Oncology doctors have vast experience, continue education constantly, participate in professional associations and have positive feedback from patients treated.
The price for the consultation on Oncology varies between experts and depends on certain factors, such as:
To schedule your visit, just submit a request on Bookimed.com. Our coordinator will contact you to discuss the time and details of the appointment, so everything will go smoothly.
We can help to find the right doctors for Oncology if you have any difficulties with a choice. Bookimed services are free for patients ♥
2022 - Present, Istanbul/Türkiye
MEMORIAL BAHCELIEVLER HOSPITAL
Internal Medicine and Medical Oncology Specialist
2021 - 2022, Istanbul/Türkiye
MEDICAL PARK BAHÇELİEVLER HOSPITAL
Internal Medicine and Medical Oncology Specialist
2017 - 2021, Istanbul/Türkiye
ISTANBUL NEW CENTURY UNIVERSITY GAZİOSMANPAŞA HOSPITAL
Internal Medicine and Medical Oncology Specialist
2013 - 2017, Van/Türkiye
VAN YUZUNCUYIL UNIVERSITY FACULTY OF MEDICINE
Internal Medicine and Medical Oncology Specialist
2011 - 2013, Van / Türkiye
VAN TRAINING AND RESEARCH HOSPITAL
Internal Medicine and Medical Oncology Specialist
2004 - 2007, Agri / Türkiye
AĞRI PATNOS STATE HOSPITAL
Internal Medicine Specialist
⸻
EDUCATION
2022
Associate Professor
2017 - 2020, Istanbul/Turkey
University of London, School of Hygiene and Tropical Medicine
Master’s Program in Clinical Trials
2013, Istanbul/Turkey
AMERICAN HOSPITAL, IVF UNIT
Ministry of Health Subspecialty Training in Reproductive Medicine
2005 - 2010, Istanbul/Turkey
İSTANBUL GÖZTEPE TRAINING AND RESEARCH HOSPITAL
Residency in Obstetrics and Gynecology
1998 - 2004, Istanbul/Turkey
İSTANBUL UNIVERSITY, CERRAHPAŞA FACULTY OF MEDICINE
Medical Doctor (M.D.) Education
Dr. Domenico Sabia is an experienced surgeon. He specializes in peritoneal oncology, melanoma and sarcoma surgery, laparoscopic and robotic surgery, and hepato-biliary and pancreatic surgery. He practices at Centro Médico Teknon and Consorci Sanitari Integral in Spain. Dr. Sabia has over 15 years of experience in treating advanced abdominal and pelvic cancers.
Dr. Sabia often speaks at national and international congresses. He has written and co-written many scientific publications. He also works as an investigator in major clinical trials in oncological surgery. He is accredited by organizations such as the Asociación Española de Cirujanos and The Peritoneal Surface Oncology Group International. Dr. Sabia is also a member of several respected surgical societies.
2018 - Present, Istanbul/Istanbul/Türkiye
MEMORIAL BAHCELIEVLER HOSPITAL
Medical Oncology Specialist
2018 - 2018, Istanbul/Istanbul/Türkiye
ISTANBUL AYDIN UNIVERSITY MEDICAL PARK FLORYA HOSPITAL
Medical Oncology Specialist
2015 - 2018, Istanbul/Istanbul/Türkiye
HASEKİ TRAINING AND RESEARCH HOSPITAL
Medical Oncology Specialist
2011 - 2014, Istanbul/Istanbul/Türkiye
ISTANBUL SCIENCE UNIVERSITY INTERNAL MEDICINE DEPARTMENT
Medical Oncology Assistant
2011 - 2011, Istanbul/Istanbul/Türkiye
KANUNİ SULTAN TRAINING AND RESEARCH HOSPITAL
Internal Medicine Specialist
2006 - 2011, Istanbul/Istanbul/Türkiye
ISTANBUL TRAINING AND RESEARCH HOSPITAL
Internal Medicine Assistant
2004 - 2005, Istanbul/Istanbul/Türkiye
ISTANBUL UNIVERSITY CERRAHPAŞA MEDICAL FACULTY BIOCHEMISTRY UNITED STATES
Research Assistant
2003 - 2004, Karabuk/Karabuk/Türkiye
KARABUK PROVINCE SAFRANBOLU NO. 3 HEALTH CENTER
General Practitioner
2018 - Present, Istanbul/Istanbul/Türkiye
MEMORIAL BAHCELIEVLER HOSPITAL
Radiation Oncology Specialist
2016 - 2018, Istanbul/Istanbul/Türkiye
ISTANBUL UNIVERSITY CERRAHPAŞA MEDICAL FACULTY
Radiation Oncology Specialist
Known Expertise
Medical Oncologist
Academic Position
Senior Lecturer
Education
Bar-Ilan University, Israel / Computational Biology
Israeli Society for Health-Tech / Fellowship by IMA/ Innovation and Entrepreneurship in Medicine and Health-Tech
Sheba Medical Center and Bar-Ilan University, Israel/ Genomics and Biomedical Informatics
Semmelweis University/Doctor of Medicine
Training and Specialization
Clinical observership in acute oncology, early phase clinical trials and lung cancer/ Guy's and St. Thomas hospital, London, England
Leader Shift, Executive Development Program, Tel-Aviv Sourasky Medical Center
Fellowship Program in Innovation and Entrepreneurship in Medicine and Health-Tech
Resident, Medical Oncology, TASMC, Israel
6th year medical school rotations, Kaplan Medical Center, Israel
Rotation, intensive care unit and pulmonology, Stony Brook hospital, NY, US
Clinical Experience
Leader of the TASMC oncology project of PSIFAS, the Israeli National Genomic Medicine Initiative
PI for study initiator trial: T-Cell Repertoire sequencing as clinical efficacy tool for pembrolizumab (with platinum based chemotherapy) in advanced NSCLC.
PI for study initiator trial: T-cell repertoire sequencing as a clinically efficacy tool for neoadjuvant immunotherapy plus platinum-doublet chemotherapy for resectable NSCLC.
Representative of the National Medical Association for the National Council for the Prevention, Diagnosis and Treatment of Malignant Diseases, as well as head of the oncology field, Leumit HMO
Consultant on drugs and operations in the field of oncology, Leumit HMO
Member of the Helsinki Committee for Clinical Studies, TASMC
Primary investigator (PI) in pharmaceutical phases I&III clinical trials Head of oncology day-care service, TASMC, Israel
Molecular Tumor Board (MTB) moderator of the Israeli Lung Cancer Society
NGS interpretation clinic alongside head of pathology, TASMC, Israel
PI for study initiator trial: Genomic Variant of BCL-2 as a Novel Predictor of Response to Paclitaxel, TASMC, Israel
Medical oncology clinic in the field of lung and breast cancer, TASMC, Israel
Leading sub-investigator (SI) in many phase I-III clinical trials in oncology, including intra-tumoral injections (mRNA, viruses and NO), TASMC, Israel
Courses
Good Clinical Practice ICH GCP R2 & Israeli MOH Guidelines Updated Course
Point-of-Care Ultrasound course, Israeli Medical Association
GCP training Bioforum
GCP training Bioforum
Investigator Site Personnel ICH GCP Training Certificate - TransCelerate BioPharma
Academic Experience
Lecturer in the Department of Medical Education at the Faculty of Medical and Health Sciences at Tel Aviv University
JIMS Journal Club - Instructor for students.
Guidance of Dr. Aviv Berkovich M.D in basic science: cfDNA NGS for identification ofprimary and acquired resistance in patients with Lung Cancer and EGFR mutations.
TASMC, Israel in collaboration with The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, NY USA
Training team for oncology residents, TASMC, Israel
Mentor for new intern, TASMC, Israel
Tutor for medical students in oncology clerkships, Tel-Aviv University, Israel
Honors
Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel
Outstanding teacher in the faculty of medicine, Tel-Aviv University, Israel
Sign of honor for reserve medical personnel for the battle in Lebanon, IDF
Completion of residency final examination (shlav Beit) with honors
Israeli society for clinical oncology and radiation therapy (ISCORT) 17 research grant competition winner
Affiliations
Israeli Medical Association (IMA)
Israeli Society for Clinical Oncology and Radiation Therapy (ISCORT)
The Israeli Lung Cancer Group (ILCG)
European Society of Medical Oncology (ESMO)
International Association for the Study of Lung Cancer (IASLC)
The International Society of Liquid Biopsy (ISLB)
The Israeli Society for Health-Tech
Boards
Co-founder, board member and treasurer of the Israeli Acute Oncology Society
Clinical Research Association Board of Directors on behalf of the Israeli Lung Cancer Group
Member of the Trustees of Oncology Innovation, TASMC, Israel
Doctor of Medical Service IDF
Areas of interest
Thoracic malignancies,
early to late phase clinical trials,
intra-tumoral injections,
comprehensive genomic profiling of tumors,
liquid biopsies: cfDNA, TCR rep-seq and epi-Genetics;
cell therapy
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
One of the best cancer specialists in Europe, educator, and cancer researcher, President of the Central European Cooperative Oncology Group (CECOG).
Has published over 600 scientific papers on cancer treatment.
Director of Radiotherapy Institute Oncology Division
Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.
Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.
Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.
Education and Expertise
Selcuk University Meram Faculty of Medicine - Medical Education
Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization
Experience
Malatya State Hospital Internal Diseases Clinic
Ankara Oncology Hospital Medical Oncology Clinic
Erzurum Regional Training and Research Hospital Medical Oncology Clinic
AREAS OF INTEREST
Lung cancer
esophageal cancer
Gastric cancer
breast cancer
Gastrointestinal surgery
https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr